BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 29086369)

  • 1. Apolipoprotein B mRNA Editing Enzyme, Catalytic Polypeptide-Like Gene Expression, RNA Editing, and MicroRNAs Regulation.
    Cao W; Wu W
    Methods Mol Biol; 2018; 1699():75-81. PubMed ID: 29086369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs regulate APOBEC gene expression.
    Cao W; Wu W
    Histol Histopathol; 2018 Feb; 33(2):117-120. PubMed ID: 28604942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between activation-induced cytidine deaminase/apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like cytidine deaminase expression, hepatitis B virus (HBV) replication and HBV-associated liver disease (Review).
    He X; Li J; Wu J; Zhang M; Gao P
    Mol Med Rep; 2015 Nov; 12(5):6405-14. PubMed ID: 26398702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein B mRNA editing enzyme catalytic polypeptide-like family genes activation and regulation during tumorigenesis.
    Gao J; Choudhry H; Cao W
    Cancer Sci; 2018 Aug; 109(8):2375-2382. PubMed ID: 29856501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Special Issue "APOBECs and Virus Restriction".
    Chelico L
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APOBEC: From mutator to editor.
    Yang B; Li X; Lei L; Chen J
    J Genet Genomics; 2017 Sep; 44(9):423-437. PubMed ID: 28964683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AID/APOBEC-like cytidine deaminases are ancient innate immune mediators in invertebrates.
    Liu MC; Liao WY; Buckley KM; Yang SY; Rast JP; Fugmann SD
    Nat Commun; 2018 May; 9(1):1948. PubMed ID: 29769532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatable liver expression of the rabbit apolipoprotein B mRNA-editing enzyme catalytic polypeptide 1 (APOBEC-1) in mice lacking endogenous APOBEC-1 leads to aberrant hyperediting.
    Hersberger M; Patarroyo-White S; Qian X; Arnold KS; Rohrer L; Balestra ME; Innerarity TL
    Biochem J; 2003 Jan; 369(Pt 2):255-62. PubMed ID: 12374571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systems biology analysis of protein-protein interactions in the APOBEC family.
    Wang Y; Chen G; Yang Y; Hu Z; Chen X
    Life Sci; 2008 Oct; 83(15-16):521-30. PubMed ID: 18793652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addressing the benefits of inhibiting APOBEC3-dependent mutagenesis in cancer.
    Petljak M; Green AM; Maciejowski J; Weitzman MD
    Nat Genet; 2022 Nov; 54(11):1599-1608. PubMed ID: 36280735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA and RNA editing of retrotransposons accelerate mammalian genome evolution.
    Knisbacher BA; Levanon EY
    Ann N Y Acad Sci; 2015 Apr; 1341():115-25. PubMed ID: 25722083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [APOBEC3s: history of an antiviral and mutagenic protein family].
    Verriez C; Marquet R; Paillart JC; Stupfler B
    Virologie (Montrouge); 2020 Dec; 24(6):381-418. PubMed ID: 33441290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases.
    Conticello SG; Thomas CJ; Petersen-Mahrt SK; Neuberger MS
    Mol Biol Evol; 2005 Feb; 22(2):367-77. PubMed ID: 15496550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA Editing by APOBECs: A Genomic Preserver and Transformer.
    Knisbacher BA; Gerber D; Levanon EY
    Trends Genet; 2016 Jan; 32(1):16-28. PubMed ID: 26608778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the regulation of APOBEC3 expression: Current evidence and much to learn.
    Covino DA; Gauzzi MC; Fantuzzi L
    J Leukoc Biol; 2018 Mar; 103(3):433-444. PubMed ID: 29345375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APOBEC-2, a cardiac- and skeletal muscle-specific member of the cytidine deaminase supergene family.
    Liao W; Hong SH; Chan BH; Rudolph FB; Clark SC; Chan L
    Biochem Biophys Res Commun; 1999 Jul; 260(2):398-404. PubMed ID: 10403781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cytidine deaminases AID and APOBEC-1 exhibit distinct functional properties in a novel yeast selectable system.
    Krause K; Marcu KB; Greeve J
    Mol Immunol; 2006 Feb; 43(4):295-307. PubMed ID: 15963568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disproportionate relationship between APOBEC-1 expression and apolipoprotein B mRNA editing activity.
    Siddiqui JF; Van Mater D; Sowden MP; Smith HC
    Exp Cell Res; 1999 Oct; 252(1):154-64. PubMed ID: 10502408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AID and APOBECs as Multifaceted Intrinsic Virus-Restricting Factors: Emerging Concepts in the Light of COVID-19.
    Meshcheryakova A; Pietschmann P; Zimmermann P; Rogozin IB; Mechtcheriakova D
    Front Immunol; 2021; 12():690416. PubMed ID: 34276680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene transfer of cytidine deaminase apoBEC-1 lowers lipoprotein(a) in transgenic mice and induces apolipoprotein B editing in rabbits.
    Hughes SD; Rouy D; Navaratnam N; Scott J; Rubin EM
    Hum Gene Ther; 1996 Jan; 7(1):39-49. PubMed ID: 8825867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.